Skip to content
MARKETS / NYSE / OSCR
NYSE · HOSPITAL & MEDICAL SERVICE PLANS · LARGE CAP

Oscar Health, Inc. OSCR

7 fiscal years on record · USD · FY2025 reported · SEC filings only
$28.6M
▲ 39.0% YoY
$-443.2M
▼ 1842.5% YoY
$1.1B
▲ 11.4% YoY
Growth
USD 28.6M
Revenue, FY2025 · full 7-year series below
Revenue $M Net income $M
FY2025 · Revenue 28.6 · Net income -443.2
200.0M400.0M-250.0M-500.0M2019202020212022202320242025
Compound annual growth
−23.9%
3 yrs
5 yrs
10 yrs
15 yrs

Compound annual rates per period — left blank where that exact year isn't on file, the series crosses a loss, or (per-share rows) a split falls inside the window.

Profitability
−1549 cents
lost on every revenue dollar
Operating margin Net margin
FY2025 · Operating -1386.2% · Net -1549.0%
-5000%-10000%2019202020212022202320242025
ROE
FY2025 · ROE -44.5%
-500%-1000%2019202020212022202320242025

Each USD of equity lost 45 cents this year.

Cash & shareholders
returned in FY2025 · dividends + net buybacks
Free cash flow $B
FY2025 · FCF 1.1
0.4B0.8B-0.1B-0.2B2019202020212022202320242025
Net buybacks $M Dividends $M
FY2021 · Dividends — · Net buybacks -49.6
-20M-40M201920202021

Total assetsUSD 6.3B
EquityUSD 977.6M
CashUSD 2.8B
Gross debtUSD 430.1M
Net debtUSD -2.3B
Current ratio0.95×

The company holds more cash than debt.

The 7-year record
7 fiscal years
Every figure from documents filed with the SEC · USD

EPS, diluted, dividend per share and shares outstanding are shown without shading, and a vertical line marks the year the share count changed — the series crosses a large, unexplained change in share count, so the years on either side are not on a comparable scale.

row low → row highnegative
Metric 2025202420232022202120202019
Revenue $B0.00.00.00.10.00.00.5
Operating income $B−0.40.1−0.2−0.6−0.5−0.4−0.3
EBITDA $B−0.40.1−0.2−0.6−0.5−0.4−0.3
Income tax $B0.00.00.0−0.00.00.00.0
Net income $B−0.40.0−0.3−0.6−0.6−0.4−0.3
Free cash flow $B1.11.0−0.30.4−0.20.2−0.2
EPS, diluted $−1.690.10−1.22−2.85−3.20−14.16−9.06
Dividend / sh $·······
Payout %·······
ROE %−44.52.8−32.0−53.2−1253.8··

Slide the table for earlier years · "·" marks a figure not available in our data for that year.

Provenance
Company facts, as filed
How we verify · 0 failures in 26 reconciliationsAUDITED

Reconciled in 7 of 19 fiscal years. 50 checks could not be computed.

EPS recomputationBalance-sheet identityGross profitBalance-sheet liquiditymoeda_consistente0 failures
ActivityHospital & Medical Service Plans
Listed onNYSE
Incorporated inDelaware
Fiscal year endsDecember 31
Data on record since2019

Share this section

Download image